Literature DB >> 34921297

Improving outcomes in glomerular disease.

Andreas Kronbichler1,2, Rachel B Jones3,4.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 34921297     DOI: 10.1038/s41581-021-00526-z

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial.

Authors:  Richard A Furie; Gustavo Aroca; Matthew D Cascino; Jay P Garg; Brad H Rovin; Analia Alvarez; Hilda Fragoso-Loyo; Elizabeth Zuta-Santillan; Thomas Schindler; Paul Brunetta; Cary M Looney; Imran Hassan; Ana Malvar
Journal:  Ann Rheum Dis       Date:  2021-10-06       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.